A board of arbitration has determined the steelmaker has met its obligations to the United Steelworkers (USW) union in ...
Capricor announced it intends to file a BLA for deramiocel for treatment of patients with DMD cardiomyopathy. Click here to ...
Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced it has completed a successful pre-Biologics ...
Enrollment for cohorts 2a, 2b, and 3 is expected to begin in the fourth quarter of 2024. The Company remains on track to file a Biologics License Application (BLA) for detalimogene in its pivotal ...
Brazilian Legal Amazonia (BLA)—which comprises the entirety of the Amazon Basin located in Brazil and vast adjacent swathes ...
Capricor Therapeutics Inc (NASDAQ:CAPR) shares are trading higher Tuesday after the company announced intent to file a ...
AstraZeneca AZN and Japanese partner Daiichi Sankyo announced that their antibody-drug conjugate, datopotamab deruxtecan ...
The recent escalation in terrorism within Pakistan has cast significant doubts on the efficacy of the state's security ...